CytoVale is a California-based medical device company that develops and commercializes diagnostic test kits for the early detection of immune-mediated diseases... Read more
CytoVale is a California-based medical device company that develops and commercializes diagnostic test kits for the early detection of immune-mediated diseases... Read more
News
Jan 12, 2026
StreetInsider
Press Release: Cytovale : Cytovale's IntelliSep Named Modern Healthcare's Best in Business for Second Consecutive Year
Dec 10, 2025
PR Newswire
Press Release: Cytovale : Rapid Sepsis Test Enables Hospital to Reduce Mortality by 42% and Shorten Hospital Stay by Two Days, According to Academic Medical Center Study
Sep 07, 2025
PR Newswire
Press Release: Cytovale : New Data Reveals Path to SEP-1 Success Includes Early Sepsis Risk Stratification
Jun 12, 2025
StreetInsider
Press Release: Cytovale : Cytovale's Rapid Diagnostic Slashes Sepsis Mortality by 39%, Peer-Reviewed Study Confirms
Feb 04, 2025
PR Newswire
Cytovale: Cytovale Names Dave Vort Chief Commercial Officer
Dec 09, 2024
PR Newswire
Press Release: Cytovale : Cytovale Recognized as One of Modern Healthcare's 2024 Best in Business
Dec 04, 2024
StreetInsider
Press Release: Cytovale : Hospital Brings Life-Saving Sepsis Detection Technology to Rural Louisiana
Oct 30, 2024
PR Newswire
Press Release: Cytovale : Cytovale's Sepsis Solution Now Available Across Franciscan Missionaries of Our Lady Health System in Louisiana and Mississippi
May 02, 2024
StreetInsider
Press Release: Cytovale : Cytovale's Diagnostic Test Demonstrates Strong Performance in Rapid Identification of Sepsis Risk, Peer-Review Study Confirms
Dec 05, 2023
HIT Consultant Media
Cytovale: Cytovale Secures $84M for Transformative Sepsis Diagnostic Tool
Cytovale Competitors
1
2
3
4
5
6
7
8
9
10